MAPK3 and endometrial cancer: G36 inhibits E2 and G-1-dependent calcium mobilization as well as erk-1/2 activation in SKBR3 cells (IC50 = 200 nM) and blocks the growth of transplanted estrogen-dependent type II endometrial cancer cells (63).